What's breaking now, across thousands of outlets.
The pharma industry has suffered a definitive loss in its legal battle against Medicare negotiations. The Fifth Circuit Court of Appeals on Wednesday rejected a challenge brought by the industry trade ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The Phase I dose escalation trial of ACESOT-1051 (NCT06260514) will accelerate its patient enrollment, with Aprea planning to more than triple its number of active clinical sites for the study from…
In the latest in a string of setbacks in biopharma’s efforts to fight Medicare drug price negotiations, a lawsuit from the industry’s top lobbying group has been rejected at the appeals level.
The study looked at high-risk Maven members with hypertension or diabetes, compared to CDC data.
Akwa Ibom State Government says it has banned the use of ambulances to convey corpses for burial across the state, saying such an act poses a public health threat.
Pet insurance can affect the financial side of veterinary care, but there are other important limits to understand.
